Newfoundland and Labrador's health officials are optimistic that everyone in the province who wants a COVID-19 vaccine will be able to get one by July this year, but with varying efficacy rates of the ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing ...

The U.S. FDA has agreed to review Moderna’s mRNA flu vaccine after initially declining, as next-generation RSV vaccines advance to address evolving viral strains. RSV continues to pose risks for older ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis ...

Feb. 20 (UPI) --Regulatory predictability is crucial for vaccine makers as they plan trials for future products but shakeups in the United States' top health agencies are making the process more ...